AbbVie Inc. (FRA:4AB)
169.80
-2.00 (-1.16%)
Last updated: Aug 13, 2025
AbbVie Revenue
AbbVie had revenue of $15.42B USD in the quarter ending June 30, 2025, with 6.65% growth. This brings the company's revenue in the last twelve months to $58.33B, up 6.05% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$58.33B
Revenue Growth
+6.05%
P/S Ratio
6.05
Revenue / Employee
$1.06M
Employees
55,000
Market Cap
300.59B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 123.69B |
Siemens Energy AG | 38.39B |
Rheinmetall AG | 10.67B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 63.03B |
Deutsche Bank Aktiengesellschaft | 30.07B |
AbbVie News
- 5 days ago - AbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules - Benzinga
- 5 days ago - Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79% - Benzinga
- 5 days ago - Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79% - Benzinga
- 7 days ago - Get Ready, JUVÉDERM® Day is Calling! - PRNewsWire
- 7 days ago - AbbVie (ABBV) Stock Signal: How Strong is the Double Top Formation? - 06 August 2025 - DailyForex
- 8 days ago - Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency - PRNewsWire
- 8 days ago - AbbVie (ABBV) Q2 2025 Earnings Call Transcript - The Motley Fool
- 9 days ago - AbbVie Raises 2025 Outlook After Q2 Beat - The Motley Fool